Martini-Klinik, University Hospital Hamburg-Eppendorf
Head of the Prostate Cancer Outpatient Clinic
Since 2002
University Medical Center Hamburg-Eppendorf
View more
Education
Research assistant at the Department of Urology
1995 to 2005
University of Hamburg
Habilitation - venia legendi for the subject urology
2002
Hamburg
DFG Scholar
2000 to 2001
Memorial Sloan Kettering Cancer Center New York
View more
Pubmed
Adherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D'Amico lymph node invasion risk stratification.
2017
Urologic oncology
Read it here
Deletion of 8p is an independent prognostic parameter in prostate cancer.
2017
Oncotarget
Read it here
Oncologic and Functional Outcomes after Radical Prostatectomy for High or Very High Risk Prostate Cancer: European Validation of the Current NCCN® Guideline.
European Association of Urology (EAU)MemberAmerican Urology Association (AUA)MemberGerman Society of UrologyMember
View more
Honors
Peter Bischoff PrizeNorth German Society of Urology
2011
Peter Bischoff PrizeNorth German Society of Urology
2008
Peter Bischoff PrizeNorth German Society of Urology
2005
View more
Get updatedReceive the latest news from Prof. Markus Graefen, MD
Reviews
Global Review
4.7 /5
Pedagogy
4.6 /5
Hospitality
4.6 /5
Knowledge aquired
4.7 /5
Recommendation
4.7 /5
Nov 8, 2020
Dr. Iraklis P.
Aug 2, 2020
Dr. Eliza Cristina B.Thank for organizing it!
Jul 13, 2020
Dr. Maksym M.
Jun 27, 2020
Dr. Fang Jann L.
Jun 7, 2020
Rodrigo E.
Jun 5, 2020
Dr. Joao A.
Jun 5, 2020
Dr. Tigran O.
Jun 4, 2020
Dr. marco a.
Jun 4, 2020
Dr. Rui F.
Jun 4, 2020
Dr. Cristian Nicolae M.You are the best ;)
Jun 4, 2020
Nicanor R.
May 17, 2020
Dr. Dimitrios M.
May 16, 2020
Dr. Artur P.
May 15, 2020
Dr. Igor S.
May 14, 2020
Rui B.
May 13, 2020
Tomislav K.
May 12, 2020
Dr. Andreas K.
May 12, 2020
Dr. Vasile Cristian C.
May 12, 2020
Dr. Jose Antonio B.
May 12, 2020
Alexander H.
May 12, 2020
ALIAKSANDR B.
May 12, 2020
Karel D.
May 12, 2020
Said C.
May 10, 2020
Dr. Kevin L.
May 9, 2020
Toon M.It was nearly impossible to understand the speaker because some participants had their micros turned on
May 9, 2020
Dr. LORENA F.
May 8, 2020
IOANNIS L.
May 7, 2020
Dr. Palagonia E.
May 7, 2020
Dr. Ruben U.Congrats. PLease keep on doing these courses.
May 7, 2020
Muhammad A.
May 7, 2020
Alex R.
May 7, 2020
Ahmad A.The speaker should be a zoom-oriented user, as some time spent in setting up some of the share screen options.
To limit seats per webinar, to facilitate interaction between audience and speaker.
To label admin per webinar session to receive the questions, rather than the common chat window.
To assure the speaker has high internet speed with HD streaming capabilities, as the shared videos were of low quality at streaming from zoom.
May 7, 2020
Dr. Savchuk R.More surgery
May 6, 2020
Juan Carlos A.
May 6, 2020
Dr. Muhannad A.
May 6, 2020
Dr. Miguel S.
May 6, 2020
Janusz L.
May 6, 2020
Dr. Dimitri B.
May 6, 2020
Gaelle F.
May 6, 2020
Filip R.
May 6, 2020
Dr. Viachaslau S.I like this course very much!
May 6, 2020
Felipe V.
May 6, 2020
Dr. Bernardo G.Estoy muy interesado en seguir participando en los próximos eventos y tratar de difundirlo y poder convocar a la gente que tengo en entrenamiento en Urología en la Ciudad de México
Muchas gracias
May 6, 2020
Carmelo M.
May 6, 2020
Dr. Sani A.
May 6, 2020
Tareq A.
May 6, 2020
Anastasia P.
May 6, 2020
Ben E.
May 6, 2020
Roman F.Perfect webinar.High level Of profesionality.Very useful for robotic surgeons.
May 6, 2020
Dr. Sunil S.Learnt a lot
May 6, 2020
Bikheet A.
May 6, 2020
Dr. Yavor S.Very good seminar. Hope to have more events in the near future.
May 6, 2020
Dr. Adam N.
May 6, 2020
Swan Pai O.That’s a really amazing webinar and hope more are coming soon
May 6, 2020
Carmine F.
May 6, 2020
Rodrigo G.
May 6, 2020
Dr. Anna W.Good to think outside the box for training at the moment. I'm a robotic fellow not getting to operate soore modular sessions on ralp would be welcome
May 6, 2020
Felipe V.
May 6, 2020
Dr. Juan O.The surgical videos displayed were often interrupted, not continuos, beside that everything was ok .
May 6, 2020
Piotr K.
May 6, 2020
Dr. Faran K.
May 6, 2020
Dr. Julius v.
May 6, 2020
Sebastian O.Very good webinar!
May 6, 2020
Bikheet A.
May 6, 2020
Tommaso C.
Work ExperienceProfessor of Urology
Since 2007
University of Hamburg
Chief PhysicianProstate Cancer Center
Since 2005
Martini-Klinik, University Hospital Hamburg-Eppendorf
Head of the Prostate Cancer Outpatient Clinic
Since 2002
University Medical Center Hamburg-Eppendorf
Senior Physician
2002 to 2004
University Medical Center Hamburg-Eppendorf
EducationResearch assistant at the Department of Urology
1995 to 2005
University of Hamburg
Habilitation - venia legendi for the subject urology
2002
Hamburg
DFG Scholar
2000 to 2001
Memorial Sloan Kettering Cancer Center New York
Board certification
1999
Hamburg
Research assistant at the Department of Urology
1993 to 1995
Teaching Hospital of the University of Dusseldorf
General Surgery Degree
1992 to 1993
Blackburn & Edinburgh
Medical Degree
1986 to 1992
Bonn
PubmedAdherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D'Amico lymph node invasion risk stratification.
2017
Urologic oncology
Read it here
Deletion of 8p is an independent prognostic parameter in prostate cancer.
2017
Oncotarget
Read it here
Oncologic and Functional Outcomes after Radical Prostatectomy for High or Very High Risk Prostate Cancer: European Validation of the Current NCCN® Guideline.
2017
The Journal of urology
Read it here
Adjuvant and Salvage Radiotherapy after Radical Prostatectomy in Prostate Cancer Patients.
2017
European urology
Read it here
Radical prostatectomy neutralizes obesity-driven risk of prostate cancer progression.
2017
Urologic oncology
Read it here
Population-Based Validation of the 2014 ISUP Gleason Grade Groups in Patients Treated With Radical Prostatectomy, Brachytherapy, External Beam Radiation, or no Local Treatment.
2017
The Prostate
Read it here
High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer.
2017
International journal of molecular sciences
Read it here
Correction: Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer.
2017
Oncotarget
Read it here
Integrating Tertiary Gleason 5 Patterns into Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens.
2017
European urology
Read it here
North American Population-Based Validation of the National Comprehensive Cancer Network Practice Guideline Recommendation of Pelvic Lymphadenectomy in Contemporary Prostate Cancer.
2017
The Prostate
Read it here
Prognostic value of the new Grade Groups in Prostate Cancer: a multi-institutional European validation study.
2017
Prostate cancer and prostatic diseases
Read it here
Ten-year experience of robot-assisted radical prostatectomy: the road from cherry-picking to standard procedure.
2017
Minerva urologica e nefrologica = The Italian journal of urology and nephrology
Read it here
[Phase II study with metastatic castration-resistant prostate cancer (mCRPC) patients].
2017
Der Urologe. Ausg. A
Read it here
Functional Outcomes and Quality of Life After Radical Prostatectomy Only Versus a Combination of Prostatectomy with Radiation and Hormonal Therapy.
2017
European urology
Read it here
Effect of repeat prostate biopsies on functional outcomes after radical prostatectomy.
2017
Urologic oncology
Read it here
Low-risk Prostate Cancer: Identification, Management, and Outcomes.
2017
European urology
Read it here
Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer.
2017
Carcinogenesis
Read it here
Comorbidity and age cannot explain variation in life expectancy associated with treatment of non-metastatic prostate cancer.
2017
World journal of urology
Read it here
High Chance of Late Recovery of Urinary and Erectile Function Beyond 12 Months After Radical Prostatectomy.
2017
European urology
Read it here
Adjuvant radiation therapy is associated with better oncological outcome compared with salvage radiation therapy in patients with pN1 prostate cancer treated with radical prostatectomy.
2017
BJU international
Read it here
Use of adjuvant chemotherapy in radical cystectomy patients aged >65 years: a population-based study from the surveillance epidemiology and end results (SEER)-medicare database.
2017
Minerva urologica e nefrologica = The Italian journal of urology and nephrology
Read it here
Population-Based External Validation of the Updated 2012 Partin Tables in Contemporary North American Prostate Cancer Patients.
2017
The Prostate
Read it here
The Impact of Repeat Prostate Biopsies on Oncologic, Pathological and Perioperative Outcomes after Radical Prostatectomy.
2017
The Journal of urology
Read it here
Differences in Patient Characteristics among Men Choosing Open or Robot-Assisted Radical Prostatectomy in Contemporary Practice - Analysis of Surveillance, Epidemiology, and End Results Database.
2017
Urologia internationalis
Read it here
Primary Gleason pattern upgrading in contemporary patients with D'Amico low-risk prostate cancer: implications for future biomarkers and imaging modalities.
2017
BJU international
Read it here
A proposal of a new nomogram for predicting upstaging in contemporary D'Amico low-risk prostate cancer patients.
2017
World journal of urology
Read it here
Tumor volume improves the long-term prediction of biochemical recurrence-free survival after radical prostatectomy for localized prostate cancer with positive surgical margins.
2017
World journal of urology
Read it here
Association between Lymph Node Counts and Oncological Outcomes in Lymph Node Positive Prostate Cancer.
2017
European urology focus
Read it here
High concordance of findings obtained from transgluteal magnetic resonance imaging - and transrectal ultrasonography-guided biopsy as compared with prostatectomy specimens.
2017
BJU international
Read it here
[Phase III study for local or locally advanced prostate cancer : Randomized, double-blind, placebo-controlled phase 3 study of apalutamide in patients with local high-risk prostate cancer or locally advanced prostate cancer receiving primary radiotherapy (ATLAS) - study AP 90/15 of the AUO].
2017
Der Urologe. Ausg. A
Read it here
Long-term survival of patients aged 80 years or older treated with radical prostatectomy for prostate cancer.
2017
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Read it here
Long-term oncological outcomes in patients with limited nodal disease undergoing radical prostatectomy and pelvic lymph node dissection without adjuvant treatment.
2017
World journal of urology
Read it here
Radical prostatectomy or radiotherapy reduce prostate cancer mortality in elderly patients: a population-based propensity score adjusted analysis.
2017
World journal of urology
Read it here
FOXA1 expression is a strong independent predictor of early PSA recurrence in ERG negative prostate cancers treated by radical prostatectomy.
2017
Carcinogenesis
Read it here
Summary statement on screening for prostate cancer in Europe.
2017
International journal of cancer
Read it here
Are the Results of the Prostate Testing for Cancer and Treatment Trial Applicable to Contemporary Prostate Cancer Patients Treated with Radical Prostatectomy? Results from Two High-volume European Institutions.
2017
European urology focus
Read it here
Clinical Case Discussion: Primary Treatment for Prostate Cancer in an Elderly Man-Treatment of the Primary Tumor is Necessary.
2017
European urology focus
Read it here
[Radical prostatectomy in locally advanced prostate cancer].
2017
Der Urologe. Ausg. A
Read it here
[Phase II study of pembrolizumab (MK-3475) in patients with metastatic castration-resistant prostate cancer (KEYNOTE-199)-study AP 93/16 of the AUO].
2017
Der Urologe. Ausg. A
Read it here
Comparison of 11 Active Surveillance Protocols in Contemporary European Men Treated With Radical Prostatectomy.
2017
Clinical genitourinary cancer
Read it here
Local Therapy Improves Survival in Metastatic Prostate Cancer.
2017
European urology
Read it here
High-Level Glyoxalase 1 (GLO1) expression is linked to poor prognosis in prostate cancer.
2017
The Prostate
Read it here
Short- and Long-term Functional Outcomes and Quality of Life after Radical Prostatectomy: Patient-reported Outcomes from a Tertiary High-volume Center.
2017
European urology focus
Read it here
Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate Cancer.
2017
Neoplasia (New York, N.Y.)
Read it here
Assessment of Oncological Outcomes After Radical Prostatectomy According to Preoperative and Postoperative Cancer of the Prostate Risk Assessment Scores: Results from a Large, Two-center Experience.
2017
European urology focus
Read it here
First North American validation and head-to-head comparison of four preoperative nomograms for prediction of lymph node invasion before radical prostatectomy.
2017
BJU international
Read it here
Radical prostatectomy in oligometastatic prostate cancer.
2017
Current opinion in urology
Read it here
Trends in Radical Prostatectomy Risk Group Distribution in a European Multicenter Analysis of 28 572 Patients: Towards Tailored Treatment.
2017
European urology focus
Read it here
Survival Among Men at High Risk of Disseminated Prostate Cancer Receiving Initial Locally Directed Radical Treatment or Initial Androgen Deprivation Therapy.
2017
European urology
Read it here
Impact of preoperative risk on metastatic progression and cancer-specific mortality in patients with adverse pathology at radical prostatectomy.
2017
BJU international
Read it here
Income and health-related quality of life among prostate cancer patients over a one-year period after radical prostatectomy: a linear mixed model analysis.
2017
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
Read it here
Defining biochemical recurrence after radical prostatectomy and timing of early salvage radiotherapy : Informing the debate.
2017
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]
Read it here
The survival impact of neoadjuvant hormonal therapy before radical prostatectomy for treatment of high-risk prostate cancer.
2017
Prostate cancer and prostatic diseases
Read it here
External Beam Radiotherapy Affects Serum Testosterone in Patients With Localized Prostate Cancer.
2017
The journal of sexual medicine
Read it here
Reply to Paolo Capogrosso, Francesco Montorsi, and Andrea Salonia's Letter to the Editor re: Philipp Mandel, Felix Preisser, Markus Graefen, et al. High Chance of Late Recovery of Urinary and Erectile Function Beyond 12 Months After Radical Prostatectomy. Eur Urol 2017;71:848-50. Late Recovery of Erectile Function After Radical Prostatectomy: Should We Modify the Way of Assessment?
2017
European urology
Read it here
The EMPaCT Classifier: A Validated Tool to Predict Postoperative Prostate Cancer-related Death Using Competing-risk Analysis.
2017
European urology focus
Read it here
Incidence, Risk Factors, Management, and Complications of Rectal Injuries During Radical Prostatectomy.
2017
European urology focus
Read it here
Survival Outcomes in Octogenarian and Nonagenarian Patients Treated with First-line Androgen Deprivation Therapy for Organ-confined Prostate Cancer.
2017
European urology focus
Read it here
Does Cytoreductive Prostatectomy Really Have an Impact on Prognosis in Prostate Cancer Patients with Low-volume Bone Metastasis? Results from a Prospective Case-Control Study.
2017
European urology focus
Read it here
A Critical Analysis of the Current Knowledge of Surgical Anatomy of the Prostate Related to Optimisation of Cancer Control and Preservation of Continence and Erection in Candidates for Radical Prostatectomy: An Update.
2016
European urology
Read it here
Differences in Patient Characteristics Among Men Choosing Open or Robot-Assisted Radical Prostatectomy in Contemporary Practice at a European High-Volume Center.
2016
Urologia internationalis
Read it here
Cytoplasmic accumulation of ELAVL1 is an independent predictor of biochemical recurrence associated with genomic instability in prostate cancer.
2016
The Prostate
Read it here
The Combination of DNA Ploidy Status and PTEN/6q15 Deletions Provides Strong and Independent Prognostic Information in Prostate Cancer.
2016
Clinical cancer research : an official journal of the American Association for Cancer Research
Read it here
Oncological, functional and perioperative outcomes in transplant patients after radical prostatectomy.
2016
World journal of urology
Read it here
Prognostic Significance of Incidental Prostate Cancer at Radical Cystoprostatectomy for Bladder Cancer.
2016
Urologia internationalis
Read it here
Tumor Characteristics and Oncologic Outcome after Radical Prostatectomy in Men 75 Years Old or Older.
2016
The Journal of urology
Read it here
Additional elastography-targeted biopsy improves the agreement between biopsy Gleason grade and Gleason grade at radical prostatectomy.
2016
World journal of urology
Read it here
Very long-term survival patterns of young patients treated with radical prostatectomy for high-risk prostate cancer.
2016
Urologic oncology
Read it here
Aquaporin 5 expression is frequent in prostate cancer and shows a dichotomous correlation with tumor phenotype and PSA recurrence.
2016
Human pathology
Read it here
Five-year biochemical recurrence-free and overall survival following high-dose-rate brachytherapy with additional external beam or radical prostatectomy in patients with clinically localized prostate cancer.
2016
Urologic oncology
Read it here
Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens.
2016
European urology
Read it here
Detailed Quantification of High-grade Cancer Allows Precise Prediction of Prostate Cancer Prognosis.
2016
European urology
Read it here
When Should a Positive Surgical Margin Ring a Bell? An Analysis of a Multi-Institutional Robot-Assisted Laparoscopic Radical Prostatectomy Database.
2016
Journal of endourology
Read it here
Reduced AZGP1 expression is an independent predictor of early PSA recurrence and associated with ERG-fusion positive and PTEN deleted prostate cancers.
2016
International journal of cancer
Read it here
Prostate cancer patients' quality of life assessments across the primary treatment trajectory: 'True' change or response shift?
2016
Acta oncologica (Stockholm, Sweden)
Read it here
Intermediate-term cancer control outcomes in prostate cancer patients treated with robotic-assisted laparoscopic radical prostatectomy: a multi-institutional analysis.
2016
World journal of urology
Read it here
Deletion of 18q is a strong and independent prognostic feature in prostate cancer.
2016
Oncotarget
Read it here
Older patients with low Charlson score and high-risk prostate cancer benefit from radical prostatectomy.
2016
World journal of urology
Read it here
Suboptimal use of neoadjuvant chemotherapy in radical cystectomy patients: A population-based study.
2016
Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Read it here
Impact of Lymph Node Burden on Survival of High-risk Prostate Cancer Patients Following Radical Prostatectomy and Pelvic Lymph Node Dissection.
2016
Frontiers in surgery
Read it here
Suboptimal use of pelvic lymph node dissection: Differences in guideline adherence between robot-assisted and open radical prostatectomy.
2016
Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Read it here
p16 upregulation is linked to poor prognosis in ERG negative prostate cancer.
2016
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Read it here
[PROKOMB - prostate-cooperative MRI project Berlin-study AP 95/16 of the AUO].
2016
Der Urologe. Ausg. A
Read it here
Impact of perioperative administration of 6 % hydroxyethyl starch 130/0.4 on serum cystatin C-derived renal function after radical prostatectomy: a single-centre retrospective study.
2016
BMC anesthesiology
Read it here
Low Other Cause Mortality Rates Reflect Good Patient Selection in Patients with Prostate Cancer Treated with Radical Prostatectomy.
2016
The Journal of urology
Read it here
Heterogeneity of ERG expression in prostate cancer: a large section mapping study of entire prostatectomy specimens from 125 patients.
2016
BMC cancer
Read it here
[Social Inequality in Utilization of Aftercare Services Among Breast and Prostate Cancer Patients].
2016
Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))
Read it here
Socioeconomic status and health-related quality of life among patients with prostate cancer 6 months after radical prostatectomy: a longitudinal analysis.
2016
BMJ open
Read it here
Clinical performance of prostate health index in men with tPSA>10ng/ml: Results from a multicentric European study.
2016
Urologic oncology
Read it here
Impact of surgeon-defined capsular incision during radical prostatectomy on biochemical recurrence rates.
2016
World journal of urology
Read it here
Posterior musculofascial reconstruction after radical prostatectomy: an updated systematic review and a meta-analysis.
2016
BJU international
Read it here
Medical management of benign prostatic hyperplasia: Results from a population-based study.
2016
Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Read it here
The Role of Pelvic Lymph Node Dissection During Radical Prostatectomy in Patients With Gleason 6 Intermediate-risk Prostate Cancer.
2016
Urology
Read it here
Assessment of the Rate of Adherence to International Guidelines for Androgen Deprivation Therapy with External-beam Radiation Therapy: A Population-based Study.
2016
European urology
Read it here
[Systematic analysis of treatment results as a quality control instrument using the example of a large European center].
2015
Der Urologe. Ausg. A
Read it here
Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters.
2015
Carcinogenesis
Read it here
["Expanded prostate cancer index composite" (EPIC-26): Results of functional treatment in patients with localized prostate cancer].
2015
Der Urologe. Ausg. A
Read it here
Adjuvant Radiotherapy in Prostate Cancer Patients Treated with Surgery: The Impact of Age and Tumor Characteristics.
2015
European urology focus
Read it here
Comparison of Two Prostate Cancer Risk Calculators that Include the Prostate Health Index.
Professional AssociationsEuropean Association of Urology (EAU)MemberAmerican Urology Association (AUA)MemberGerman Society of UrologyMemberEuropean Urologic Robotic SectionMember of the BoardWorking Group Urological OncologyBoard memberEuropean Guidelines CommissionMemberGerman S3 Guidelines CommissionMemberEuropean Urology Editorial BoardMember
HonorsPeter Bischoff PrizeNorth German Society of Urology
2011
Peter Bischoff PrizeNorth German Society of Urology
2008
Peter Bischoff PrizeNorth German Society of Urology
2005
Peter Bischoff PrizeNorth German Society of Urology
2004
Peter Bischoff PrizeNorth German Society of Urology
2003
Peter Bischoff PrizeNorth German Society of Urology
2000
GE Konjetzny PrizeHamburg Cancer Society
1998
Step 1 Email
Step 2 Password
Step 3 Speciality
Step 1 Email
Step 2 Password
Step 3 Speciality
Log in
Don’t have an account yet? Create your account
Or log in with your email address
Reset Password
Enter the email address associated with your account, and we’ll email you a link to reset your password.
Don’t have an account yet? Create your account
Create your password
Invivox is a website dedicated to Healthcare professionals and Lifesciences stakeholders